The Systemic Capillary Leak Syndrome: Appearance of Interleukin-2-Receptor-Positive Cells during Attacks
1990; American College of Physicians; Volume: 113; Issue: 6 Linguagem: Inglês
10.7326/0003-4819-113-6-475
ISSN1539-3704
AutoresMarco Cicardi, M. Gardinali, Giuliana Bisiani, Alberto Rosti, Paola Allavena, A Agostoni,
Tópico(s)Electrolyte and hormonal disorders
ResumoBrief Reports15 September 1990The Systemic Capillary Leak Syndrome: Appearance of Interleukin-2-Receptor-Positive Cells during AttacksMarco Cicardi, MD, Marco Gardinali, MD, Giuliana Bisiani, MD, Alberto Rosti, MD, Paola Allavena, MD, Angelo Agostoni, MDMarco Cicardi, MDSearch for more papers by this author, Marco Gardinali, MDSearch for more papers by this author, Giuliana Bisiani, MDSearch for more papers by this author, Alberto Rosti, MDSearch for more papers by this author, Paola Allavena, MDSearch for more papers by this author, Angelo Agostoni, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-113-6-475 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptRecurrent hypovolemic shock due to leakage of plasma from the vascular space without an apparent cause was first described by Clarkson and colleagues (1) in 1960 and was subsequently characterized as systemic capillary leak syndrome (2). Since then, 18 patients have been described, most of whom had an M component in their plasma (3). However, the pathogenesis of this syndrome remains unknown. A clue may come from the fact that the syndrome is also a major complication of treatment of metastatic cancer with interleukin-2 alone or in combination with lymphokine-activated killer cells (4). Studies in animals and in humans showed...References1. ClarksonThompsonHorwithLuckey BDMH. Cyclical edema and shock due to increased capillary permeability. Am J Med. 1960;29:193-216. CrossrefMedlineGoogle Scholar2. AtkinsonWaldmannStein JTS. Systemic capillary leak syndrome and monoclonal IgG gammopathy. Medicine (Baltimore). 1977;56:225-39. CrossrefMedlineGoogle Scholar3. AgostoniCicardiGardinali AMM. Systemic capillary leak syndrome. In: Strano A, Novo S, eds. Advances in Vascular Pathology 1989. Volume 3. Excerpta Medica; Amsterdam: Excerpta Medica; [In press]. Google Scholar4. RosenbergLotzeMuul SML. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. N Engl J Med. 1987;316:889-97. CrossrefMedlineGoogle Scholar5. RosensteinEttinghausenRosenberg MSS. Extravasation of intravascular fluid mediated by systemic administration of recombinant interleukin 2. J Immunol. 1986;137:1735-42. MedlineGoogle Scholar6. CotranPoberGimbrone RJM. Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome. J Immunol. 1987;139:1883-8. Google Scholar7. KotasekVercellottiOchoaBachWhiteJacob DGAFJH. Mechanism of cultured endothelial injury induced by lymphokine-activated killer cells. Cancer Res. 1988;48:5528-32. MedlineGoogle Scholar8. WalzZankerWeider GBK. Similar effect of cyclosporine and verapamil on lymphokine, interleukin 2 receptor and protooncogene expression. Transplantation. 1989;47:331-4. CrossrefMedlineGoogle Scholar9. Waldmann T. The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science. 1986;232:727-32. CrossrefMedlineGoogle Scholar10. EwanLachmannMoriceForster PPAP. Treatment of systemic capillary leak syndrome [Letter]. Lancet. 1988;2:1496. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: From Clinica Medica Universitàdi Milano and Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. For current author addresses, see end of text. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByConsider systemic capillary leak syndrome in monoclonal gammopathy with shockSyndrome de fuite capillaire idiopathique : 2 cas cliniques de présentation trompeuseExploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune HepatitisA Rare Case of Idiopathic Capillary Leak SyndromeIdiopathic systemic capillary leak syndrome – An often missed diagnosisMyocardial oedema in an 8-year-old Chinese boy with Idiopathic systemic capillary leak syndromeSystemic Capillary Leak Syndrome (Clarkson Syndrome) in Cancer Patients: A Systematic ReviewIdiopathic systemic capillary leak syndrome presenting as septic shock: A case reportRecognition and management of idiopathic systemic capillary leak syndrome: an evidence-based reviewThe Role of Failing Autonomic Nervous System on Life-Threatening Idiopathic Systemic Capillary Leak SyndromeClinical Presentation, Management, and Prognostic Factors of Idiopathic Systemic Capillary Leak Syndrome: A Systematic ReviewDiagnostic et prise en charge du syndrome de fuite capillaire idiopathique (SFCI)Systemic capillary leak syndrome and autoimmune diseases: A case seriesIdiopathic Systemic Capillary Leak Syndrome (Clarkson Disease)A fatal case of acute progression of generalized edema and simultaneous flash pulmonary edema in a patient with idiopathic systemic capillary leak syndrome: a case reportSyndrome de fuite capillaire idiopathique et formes secondaires : une revue systématique de la littératureSystemic capillary leak syndrome complicated by severe rhabdomyolysis: A case report with review of literatureSystemic Capillary Leak Syndrome: Is Methylene Blue the Silver Bullet?A 40-year-old man with recurrent fainting, hypotension, lower limb edema and oliguria with body weight gain and secondary erythrocytosisEmerging Adverse Cutaneous Drug ReactionsSystemic Capillary Leak Syndrome as an Initial Presentation of ALK-Negative Anaplastic Large Cell LymphomaA Case of Chronic Renal Failure Associated with Systemic Capillary Leak SyndromeThe Systemic Capillary Leak Syndrome: A Case Series of 28 Patients From a European RegistryMarie Gousseff, MD, Laurent Arnaud, MD, Marc Lambert, MD, PhD, Arnaud Hot, MD, Mohamed Hamidou, MD, Pierre Duhaut, MD, PhD, Thomas Papo, MD, Martin Soubrier, MD, PhD, Marc Ruivard, MD, PhD, Giuseppe Malizia, MD, Nathalie Tieulié, MD, Sophie Rivière, MD, Jacques Ninet, MD, PhD, Pierre-Yves Hatron, MD, and Zahir Amoura, MD, for the Capillary Leak Syndrome RegistryIdiopathic Systemic Capillary Leak Syndrome (Clarkson's Disease): The Mayo Clinic ExperienceNarrative Review: The Systemic Capillary Leak SyndromeKirk M. Druey, MD and Philip R. Greipp, MDUrticaria and MastocytosisA case report of systemic capillary leak syndrome (Clarkson's disease)Syndrome de fuite capillaire idiopathiqueA patient with recurrent episodes of abdominal pain and hypovolemic shockSystemic capillary leak syndrome resulting in compartment syndrome and the requirement for a surgical airwayHigh-dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndromeLipothymie récidivante inexpliquée: penser au syndrome d'hyperperméabilité capillaire idiopathiqueSystemic Capillary Leak Syndrome Associated with Compartment SyndromeIdiopathic Systemic Capillary Leak Syndrome(SCLS): Case Report and Systematic Review of Cases Reported in the Last 16 yearsCytokine-Associated Angioedema Syndromes Including Episodic Angioedema with Eosinophilia (Gleich's Syndrome)Systemisches Kapillarlecksyndrom als Ursache eines Kompartmentsyndroms beider Unterschenkel und eines UnterarmsImmunoactivation and Altered Intercellular Communication Mediate the Pathophysiology of Spinal Cord InjuryIdiopathic Systemic Capillary Leak Syndrome: Cutaneous Involvement Can Be MisleadingThalidomide for systemic capillary leak syndromeElevated Serum Cytokine Levels in Mesothelioma Patients Who Have Undergone Pleurectomy or Extrapleural Pneumonectomy and Adjuvant Intraoperative Photodynamic Therapy¶Elevated Serum Cytokine Levels in Mesothelioma Patients Who Have Undergone Pleurectomy or Extrapleural Pneumonectomy and Adjuvant Intraoperative Photodynamic Therapy¶Initial Evidence of Endothelial Cell Apoptosis as a Mechanism of Systemic Capillary Leak SyndromeCapillary leak syndrome in a patient treated with interleukin 2 fusion toxin for cutaneous T-cell lymphomaSystemic capillary leak syndrome associated with rhabdomyolysis and compartment syndromeTreatment of the Systemic Capillary Leak Syndrome with Terbutaline and Theophylline: A Case SeriesNaeem K. Tahirkheli, MD and Philip R. Greipp, MDPulmonary infections associated with systemic capillary leak syndrome attacks in a patient with hypogammaglobulinemiaProgressive oedema in a 30-year-oldIdiopathic oedema with increased cytokine production: a pathogenetic link?Systemic Capillary Leak SyndromeSystemic capillary leak syndrome in a childSystemic capillary leak syndromeFulminating Systemic Capillary Leak Syndrome with Lymphocytosis and HypogammaglobulinemiaSkin complications other than pressure ulcers following spinal cord injuryClinical Skin Thickening Following Spinal Cord Injury Studied by HistopathologyThe paraproteins in systemic capillary leak syndromeIdiopathic Capillary Leak Syndrome Complicated by Massive RhabdomyolysisCirculating Levels of Soluble Interleukin 2 Receptors Are Elevated in the Sera of Humans with Spinal Cord InjuryGuest EditorialInterleukin-2 Directly Increases Albumin Permeability of Bovine and Human Vascular Endothelium In VitroPeripheral edema due to increased vascular permeability: a clinical appraisalControl of systemic capillary leak syndrome with aminophylline and terbutalineInterleukin-2, Autotolerance, and Autoimmunity 15 September 1990Volume 113, Issue 6Page: 475-477KeywordsBlood plasmaCancer treatmentCapillariesCellsChromosomesPathogenesisShockSouthern blot Issue Published: 15 September 1990 PDF DownloadLoading ...
Referência(s)